‘Honeymoon-Phase’ Chemical Partners Deliver a Toxic Drug to Tumors
March 21, 2022
Sarah Anderson asked the question: “Could the first ‘click chemistry’ treatment for cancer patients, which is already in Phase 1 clinical trials, reduce the side effects associated with chemotherapy?”
“Picture this: A chemotherapy drug courses through a patient’s veins, ready for action. The enemy tumor is in sight, fast approaching … but suddenly the toxic drug is whisked away, carried to an unsuspecting part of the body. It attacks wherever it can.” In Discover Magazine she dives into our technology, its in-human clinical trial with SQ3370 and future possibilities. Read the full article on their website.